应用预后Gleason分级分组系统评估前列腺癌远处转移结局
基于CaPSURE注册研究10529例前列腺癌患者,中位随访81个月,评估Gleason分级分组系统预测前列腺癌特异性死亡和骨转移的能力。结果显示分级分组与活检和前列腺切除标本的PCSM及骨转移风险显著相关(均p<0.01),但组V内Gleason评分合并后的两两比较不显著,受Gleason模式≥4+5患者代表性小的限制。
要点
- Gleason分级分组系统与前列腺癌特异性死亡和骨转移风险相关(均p<0.01)。
- 组V内Gleason评分合并后的两两比较不显著,受Gleason模式≥4+5患者代表性小限制。
- 该关联跨越不同治疗策略,包括根治性治疗、保守管理和初始雄激素剥夺治疗。
核心结论
- 预后Gleason分级分组系统与前列腺癌特异性死亡和骨转移风险相关,且该关联跨越不同治疗策略。
研究设计与样本
- 研究纳入CaPSURE注册研究中接受不同治疗策略(包括保守治疗和非根治性治疗)的前列腺癌患者。
- 共识别10529例前列腺癌男性,中位随访81个月(四分位距40-127)。
主要发现
- 分级分布:组I(<3+4)占64%,组II(3+4)占17%,组III(4+3)占9%,组IV(4+4)占6%,组V(≥4+5)占4%。
- 相对于分级组I,活检和前列腺切除标本的未校正PCSM和骨转移风险均与预后分级分组显著相关(均p<0.01)。
- 组V内Gleason评分合并后的两两比较不显著,但该分析受Gleason模式≥4+5男性代表性小的限制。
临床怎么用
- 原文未据此给出推荐。
局限性
- 组V内Gleason评分合并后的两两比较不显著,但该分析受Gleason模式≥4+5男性代表性小的限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is growing enthusiasm for the adoption of a novel grade grouping system to better represent Gleason scores. OBJECTIVE: To evaluate the ability of prognostic Gleason grade groups to predict prostate cancer (PCa)-specific mortality (PCSM) and bone metastatic progression. DESIGN, SETTING, AND PARTICIPANTS: We identified patients with PCa enrolled in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) registry across treatment strategies, including conservative and nondefinitive therapy. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We examined the prognostic ability of Gleason grade groups to predict risk of PCSM and bone metastasis using the Kaplan-Meier method and unadjusted and adjusted Cox proportional hazards models. RESULTS AND LIMITATIONS: We identified 10529 men with PCa followed for a median of 81 mo (interquartile range 40-127), including 64% in group I (< 3 + 4); 17% in group II (3+4); 9% in group III (4+3); 6% in group IV (4+4); and 4% in group V (≥ 4 + 5). Relative to grade group I, the unadjusted risks of PCSM and bone metastasis were significantly associated with prognostic grade groupings for both biopsy and prostatectomy samples (all p<0.01). Pairwise comparisons within Gleason sums collapsed within grade group V were not significant; however, this analysis was limited by a small representation of men with Gleason pattern ≥ 4 + 5. CONCLUSIONS: The prognostic grade grouping system is associated with risk of PCSM and metastasis across management strategies, including definitive therapy, conservative management, and primary androgen deprivation. PATIENT SUMMARY: A five-level reporting system for prostate cancer pathology is associated with the risk of late prostate cancer endpoints.
引用
- Leapman MS, Cowan JE, Simko J, et al. Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes. Eur Urol. 2016. PMID: 27940155. doi:10.1016/j.eururo.2016.11.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。